357 related articles for article (PubMed ID: 8772697)
21. Superoxide and nitroglycerin stimulate release of PGF2 alpha and TxA2 in isolated rat heart.
Gupte SA; Okada T; Ochi R
Am J Physiol; 1996 Dec; 271(6 Pt 2):H2447-53. PubMed ID: 8997304
[TBL] [Abstract][Full Text] [Related]
22. COX-2-dependent and potentially cardioprotective effects of negative inotropic substances released after ischemia.
Birkenmeier K; Staudt A; Schunck WH; Janke I; Labitzke C; Prange T; Trimpert C; Krieg T; Landsberger M; Stangl V; Felix SB
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2148-54. PubMed ID: 17660401
[TBL] [Abstract][Full Text] [Related]
23. Cyclooxygenase involvement in thromboxane-dependent contraction in rat mesenteric resistance arteries.
Bolla M; You D; Loufrani L; Levy BI; Levy-Toledano S; Habib A; Henrion D
Hypertension; 2004 Jun; 43(6):1264-9. PubMed ID: 15096470
[TBL] [Abstract][Full Text] [Related]
24. Contractile effect of endothelin in human placental veins: role of endothelium prostaglandins and thromboxane.
Le SQ; Wasserstrum N; Mombouli JV; Vanhoutte PM
Am J Obstet Gynecol; 1993 Oct; 169(4):919-24. PubMed ID: 8238149
[TBL] [Abstract][Full Text] [Related]
25. Coronary vasospastic action of thromboxane A2 in isolated, working guinea pig hearts.
Terashita ZI; Fukui H; Nishikawa K; Hirata M; Kikuchi S
Eur J Pharmacol; 1978 Dec; 53(1):49-56. PubMed ID: 738358
[TBL] [Abstract][Full Text] [Related]
26. Effects of endothelin-1 and endothelin-A receptor antagonist on recovery after hypothermic cardioplegic ischemia in neonatal lamb hearts.
Hiramatsu T; Forbess J; Miura T; Roth SJ; Cioffi MA; Mayer JE
Circulation; 1995 Nov; 92(9 Suppl):II400-4. PubMed ID: 7586445
[TBL] [Abstract][Full Text] [Related]
27. The endothelin A receptor antagonist LU 135252 protects the myocardium from neutrophil injury during ischaemia/reperfusion.
Gonon AT; Wang QD; Pernow J
Cardiovasc Res; 1998 Sep; 39(3):674-82. PubMed ID: 9861311
[TBL] [Abstract][Full Text] [Related]
28. Prostaglandin H2 as an endothelium-derived contracting factor modulates endothelin-1-induced contraction.
Asano H; Shimizu K; Muramatsu M; Iwama Y; Toki Y; Miyazaki Y; Okumura K; Hashimoto H; Ito T
J Hypertens; 1994 Apr; 12(4):383-90. PubMed ID: 8064162
[TBL] [Abstract][Full Text] [Related]
29. Myocardial dysfunction and coronary vasoconstriction induced by platelet-activating factor in the post-infarcted rabbit isolated heart.
Mickelson JK; Simpson PJ; Lucchesi BR
J Mol Cell Cardiol; 1988 Jun; 20(6):547-61. PubMed ID: 3216407
[TBL] [Abstract][Full Text] [Related]
30. Modulation of noradrenaline-induced vasoconstriction in isolated perfused mesenteric arterial beds from obese Zucker rats in the presence and absence of insulin.
He Y; MacLeod KM
Can J Physiol Pharmacol; 2002 Mar; 80(3):171-9. PubMed ID: 11991227
[TBL] [Abstract][Full Text] [Related]
31. Influence of SQ 30741 on thromboxane receptor-mediated responses in the feline pulmonary vascular bed.
McMahon TJ; Hood JS; Nossaman BD; Ibrahim IN; Feng CJ; Kadowitz PJ
J Appl Physiol (1985); 1991 Nov; 71(5):2012-8. PubMed ID: 1837015
[TBL] [Abstract][Full Text] [Related]
32. Myocardial release of endothelin (ET) and enhanced ET(A) receptor-mediated coronary vasoconstriction after coronary thrombosis and thrombolysis in pigs.
Wang QD; Uriuda Y; Pernow J; Hemsén A; Sjöquist PO; Rydén L
J Cardiovasc Pharmacol; 1995 Nov; 26(5):770-6. PubMed ID: 8637192
[TBL] [Abstract][Full Text] [Related]
33. The effect of the thromboxane A2/prostaglandin endoperoxide receptor antagonist SQ 30,741 on myocardial infarct size and blood flow during myocardial ischemia and reperfusion.
Grover GJ; Schumacher WA; Simon M; Parham C
J Cardiovasc Pharmacol; 1988 Dec; 12(6):701-9. PubMed ID: 2467089
[TBL] [Abstract][Full Text] [Related]
34. Protective effect of the specific endothelin-1 antagonist BQ610 on mechanical function and energy metabolism during ischemia/reperfusion injury in isolated perfused rat hearts.
Illing B; Horn M; Han H; Hahn S; Bureik P; Ertl G; Neubauer S
J Cardiovasc Pharmacol; 1996 Apr; 27(4):487-94. PubMed ID: 8847864
[TBL] [Abstract][Full Text] [Related]
35. Interaction of vasoactive substances released by platelet-activating factor in the rat perfused heart.
Hu WM; Man RY
Br J Pharmacol; 1991 Dec; 104(4):933-7. PubMed ID: 1810604
[TBL] [Abstract][Full Text] [Related]
36. Role of endothelin-1 and big endothelin-1 in modulating coronary vascular tone, contractile function and severity of ischemia in rat hearts.
Grover GJ; Sleph PG; Fox M; Trippodo NC
J Pharmacol Exp Ther; 1992 Dec; 263(3):1074-82. PubMed ID: 1469621
[TBL] [Abstract][Full Text] [Related]
37. Substrate competition in postischemic myocardium. Effect of substrate availability during reperfusion on metabolic and contractile recovery in isolated rat hearts.
Tamm C; Benzi R; Papageorgiou I; Tardy I; Lerch R
Circ Res; 1994 Dec; 75(6):1103-12. PubMed ID: 7955147
[TBL] [Abstract][Full Text] [Related]
38. Role of thromboxane A2/prostaglandin H2 receptor in the vasoconstrictor response of rat aorta to endothelin.
Reynolds EE; Mok LL
J Pharmacol Exp Ther; 1990 Mar; 252(3):915-21. PubMed ID: 2138670
[TBL] [Abstract][Full Text] [Related]
39. 15-F(2t)-isoprostane exacerbates myocardial ischemia-reperfusion injury of isolated rat hearts.
Xia Z; Kuo KH; Godin DV; Walker MJ; Tao MC; Ansley DM
Am J Physiol Heart Circ Physiol; 2005 Oct; 289(4):H1366-72. PubMed ID: 15937102
[TBL] [Abstract][Full Text] [Related]
40. Bosentan affects 15-F2t-isoprostane adverse effects on postischemic rat hearts.
Liu HM; Liu KX; Cheng MH; Liu Y; Lei S; Irwin MG; Xia Z
J Surg Res; 2011 Jun; 168(1):18-26. PubMed ID: 20006348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
